- Home
- HUIZ vs BOLT Comparison
HUIZ vs BOLT Comparison
Compare HUIZ & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUIZ
- BOLT
- Stock Information
- Founded
- HUIZ 2006
- BOLT 2015
- Country
- HUIZ China
- BOLT United States
- Employees
- HUIZ N/A
- BOLT N/A
- Industry
- HUIZ Specialty Insurers
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- HUIZ Finance
- BOLT Health Care
- Exchange
- HUIZ Nasdaq
- BOLT Nasdaq
- Market Cap
- HUIZ 29.1M
- BOLT 25.3M
- IPO Year
- HUIZ 2020
- BOLT 2021
- Fundamental
- Price
- HUIZ $3.74
- BOLT $0.49
- Analyst Decision
- HUIZ
- BOLT Hold
- Analyst Count
- HUIZ 0
- BOLT 5
- Target Price
- HUIZ N/A
- BOLT $1.25
- AVG Volume (30 Days)
- HUIZ 302.1K
- BOLT 184.1K
- Earning Date
- HUIZ 12-10-2024
- BOLT 11-12-2024
- Dividend Yield
- HUIZ N/A
- BOLT N/A
- EPS Growth
- HUIZ N/A
- BOLT N/A
- EPS
- HUIZ 0.29
- BOLT N/A
- Revenue
- HUIZ $170,927,079.00
- BOLT $9,779,000.00
- Revenue This Year
- HUIZ N/A
- BOLT $9.87
- Revenue Next Year
- HUIZ $10.46
- BOLT N/A
- P/E Ratio
- HUIZ $10.21
- BOLT N/A
- Revenue Growth
- HUIZ N/A
- BOLT 35.86
- 52 Week Low
- HUIZ $0.43
- BOLT $0.49
- 52 Week High
- HUIZ $10.58
- BOLT $1.56
- Technical
- Relative Strength Index (RSI)
- HUIZ 58.54
- BOLT 28.88
- Support Level
- HUIZ $2.60
- BOLT $0.50
- Resistance Level
- HUIZ $3.06
- BOLT $0.54
- Average True Range (ATR)
- HUIZ 0.94
- BOLT 0.03
- MACD
- HUIZ 0.04
- BOLT -0.01
- Stochastic Oscillator
- HUIZ 24.01
- BOLT 5.38
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.